Explicating Links between Acute Coronary Syndrome and Depression: Study Design and Methods

2006 ◽  
Vol 40 (3) ◽  
pp. 245-252 ◽  
Author(s):  
Gordon Parker ◽  
Gabriella Heruc ◽  
Therese Hilton ◽  
Amanda Olley ◽  
Heather Brotchie ◽  
...  

Objective: To describe a regional study seeking to replicate the suggested strong links whereby lifetime and post-coronary infarction depression are associated with a significant increase in mortality and cardiac morbidity, and consider the comparative influence of both depression and anxiety. Method: We detail relevant international studies and describe both the methodology as well as baseline and 1-month data from our study. Results: Over a 3-year period we recruited 489 subjects admitted to a Sydney cardiac unit with an Acute Coronary Syndrome (ACS), and assessed by a range of cardiac variables and measures of current and lifetime depression. Ninety-eight per cent of the sample were assessed one month after baseline recruitment to establish depression rates. Long-term outcome reviews of mortality and morbidity and hospitalization rates are proceeding. For those subjects who were depressed in the post-ACS period and, even more so for those who had experienced lifetime depression, distinctly higher scores on anxiety variables (and lifetime caseness for anxiety disorders) were established. Conclusions: The strong interdependence between anxiety and depression in this sample of patients admitted with an ACS will allow examination of the comparative extent to which expressions of ‘depression’ and ‘anxiety’ contribute to post-ACS morbidity.

2013 ◽  
Vol 111 (7) ◽  
pp. 80B
Author(s):  
Keiji Yamada ◽  
Satoru Sakuragi ◽  
Kota Okabe ◽  
Takashi Fuziwara ◽  
Takashi Miki ◽  
...  

2020 ◽  
Vol 62 ◽  
pp. 178-183
Author(s):  
Kimmo Koivula ◽  
Kaari K. Konttila ◽  
Markku J. Eskola ◽  
Mika Martiskainen ◽  
Heini Huhtala ◽  
...  

2019 ◽  
Vol 40 (Supplement_1) ◽  
Author(s):  
F Scudiero ◽  
R Valenti ◽  
R Marcucci ◽  
G D Sanna ◽  
A M Gori ◽  
...  

Abstract Background Coronary artery disease (CAD) has been recognized as a serious and potentially life-threatening complication of Hepatitis C Virus (HCV) infection. High on treatment platelet reactivity has been associated with high risk of ischemic events in patients with CAD, but data regarding the association with HCV infection are still lacking. Purpose We sought to assess platelet reactivity on dual anti-platelet therapy and long-term outcome of acute coronary syndrome (ACS) patients infected with HCV. Methods ACS patients infected with HCV were matched to ACS patients without HCV for age, sex, diabetes, hypertension and renal function. Primary and secondary study endpoints were the proportion of patients with high on treatment platelet reactivity (HTPR) and long-term outcomes, respectively. Results HCV-infected ACS patients had higher levels of platelet reactivity (ADP10-LTA: 56% ± 18% vs. 44% ± 22%; p=0.002; Arachidonic Acid-LTA: 25% ± 21% vs. 16% ± 15%; p=0.011) and higher rate of HTPR on clopidogrel and aspirin compared with non-HCV patients. Multivariable analysis demonstrated HCV-infection to be an independent predictor of HTPR. At follow-up, estimated major adverse clinical events (MACE: cardiac death, non fatal myocardial infarction and any revascularization) were 57% vs. 37%, p=0.006 in HCV-infected ACS and non-HCV, respectively. Also, TIMI major bleeding rates were higher in HCV-infected subjects (11% vs. 3%; p=0.043) as compared with non-infected patients. Platelet function according to HCV status Conclusions ACS patients with HCV infection have increased on treatment platelet reactivity, higher rate of HTPR, MACE and bleedings as compared with non-HCV patients.


2011 ◽  
Vol 57 (14) ◽  
pp. E1083
Author(s):  
Toru Mazaki ◽  
Hiroyoshi Yokoi ◽  
Masashi Iwabuchi ◽  
Hideyuki Nosaka ◽  
Masakiyo Nobuyoshi

CHEST Journal ◽  
2008 ◽  
Vol 134 (4) ◽  
pp. 1P
Author(s):  
Elisabete Jorge ◽  
Rui Baptista ◽  
Rogerio Teixeira ◽  
Carolina Lourenco ◽  
Natalia Antonio ◽  
...  

2015 ◽  
Vol 169 (5) ◽  
pp. 702-712.e3 ◽  
Author(s):  
Katia Orvin ◽  
Alon Eisen ◽  
Ilan Goldenberg ◽  
Ateret Farkash ◽  
Nir Shlomo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document